REVITALIZE: a telehealth program to reduce fatigue interference for adults with advanced ovarian cancer on PARP inhibitors

Who could benefit from this research

What this research studies

This project tests a remote, accessible program designed to lessen how fatigue disrupts daily life for people with advanced ovarian cancer on PARP inhibitors. The approach is built on behavioral strategies delivered through telehealth, tailored to the needs of patients living with ongoing cancer treatment. The study will measure fatigue interference, quality of life, and treatment adherence to see if the program helps patients stay on their prescribed therapy. Given the cancer context, the research focuses on real-world applicability and patient-reported outcomes that matter to daily living. Results could guide future supportive care approaches for similar cancer populations.

Why it matters

Where this research is happening

• Dana-Farber Cancer Inst
  Boston, United States Active

Researchers

• Principal investigator: Wright, Alexi a — Dana-Farber Cancer Inst
• Study coordinator: Wright, Alexi a

Related research

Other NIH-funded projects on the same topics.

• REVITALIZE: A telehealth program to help adults with advanced ovarian cancer manage fatigue while on PARP inhibitors

  This program offers a telehealth approach to help adults with advanced ovarian cancer feel less tired and improve their quality of life while taking PARP inhibitor medications.

  NIH research Dana-Farber Cancer Inst · Boston, United States · NIH-11077229

• Telehealth exercise program to help rural breast cancer survivors fight fatigue

  A telehealth exercise program is being tested to reduce cancer-related fatigue in rural breast cancer survivors.

  NIH research University of Montana · Missoula, United States · NIH-11627181

• Understanding the experience of ovarian cancer after diagnosis to improve survivorship

  This NIH grant funds a mixed-methods study to better understand physical and emotional challenges faced by ovarian cancer survivors and how supportive care can help them live better after diagnosis.

  NIH research University of Minnesota · Minneapolis, United States · NIH-11624191

• Targeting quiescent ovarian cancer cells to overcome chemotherapy resistance

  A study focusing on why some ovarian cancer cells pause dividing and resist chemotherapy, with the goal of finding new treatment targets for relapsed disease.

  NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11608576

• Photodynamic lipids to boost chemotherapy for metastatic ovarian cancer

  A patient-friendly approach tests a light-activated method to make ovarian cancer metastases more sensitive to chemotherapy.

  NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11601571

• DESCANSO: A friendly CBT plan to ease depression, sleep problems, and fatigue in Latino cancer patients

  A Spanish-speaking CBT program called DESCANSO is being tested to help Latino cancer patients feel less tired, sleep better, and happier.

  NIH research Ponce School of Medicine · Ponce, United States · NIH-11601026

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.